NASDAQ · Biotechnology

Ocular Therapeutix, Inc. (OCUL) Stock

$7.51 +3.87% NASDAQ: OCUL Healthcare

Valuation

MetricValue
Price$7.51
Market Cap$1.64B
P/E Ratio-5.56
P/B Ratio3.42
P/S Ratio33.21
EPS (TTM)$-1.44
52-Week High$16.44
52-Week Low$6.23
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-59.87%
ROA-44.90%
ROCE-50.46%
Gross Margin-519.23%
Operating Margin-8.65%
Net Margin-579.10%
Debt/Equity0.15
Current Ratio14.81

Annual Financials (USD)

Metric20212022202320242025
Revenue$44.0M$51.0M$58.0M$64.0M$52.0M
Operating Profit$-78.0M$-79.0M$-82.0M$-172.0M$-270.0M
Net Profit$-7.0M$-71.0M$-81.0M$-194.0M$-266.0M
EPS$-0.98$-0.97$-1.02$-1.22$-1.42
Op Margin-179.3%-152.7%-141.0%-269.6%-521.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$205.0M$149.0M$252.0M$458.0M$808.0M
Total Liabilities$117.0M$114.0M$161.0M$143.0M$154.0M
Cash$164.0M$102.0M$196.0M$392.0M$737.0M
Borrowings$59.0M$64.0M$83.0M$76.0M$80.0M

Latest News

Ocular Therapeutix Eyes Q4 AXPAXLI NDA After FDA Alignment MarketBeat · Jul 23, 2026 3 Cash-Burning Stocks with Open Questions StockStory · Jul 21, 2026 Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 9, 2026 3 Small-Cap Stocks with Open Questions StockStory · Jul 8, 2026 Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences GlobeNewswire · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-66.0M$-60.0M$-70.0M$-135.0M$-205.0M
Investing Cash Flow$-2.0M$-7.0M$-12.0M$-3.0M$-24.0M
Financing Cash Flow$2.0M$1.0M$-5.0M$-301.0M$0
Net Cash Flow$-64.0M$-62.0M$94.0M$196.0M$345.0M
Free Cash Flow$-67.0M$-63.0M$-76.0M$-136.0M$-217.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.49
EV / EBITDA-4.25
FCF Yield-14.76%
Quick Ratio13.03
Interest Coverage-27.53
Return 1Y-27.55%
Return 3Y94.28%
Return 5Y-29.84%

Ownership

Insiders Held0.94%
Institutions Held95.81%
Institutions Float Held96.71%
Institutional HolderSharesReport Date
FMR, LLC32,653,7642026-03-31
Deep Track Capital, Lp19,686,2822026-03-31
Blackrock Inc.16,132,9312026-03-31
Avoro Capital Advisors LLC12,315,0002026-03-31
Summer Road LLC11,879,8252026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BLCOBausch + Lomb Corporation $17.15 -1.10% -35.85 $6.13B 0.00%
EYPTEyePoint, Inc. $3.46 +4.22% -0.91 $290.09M 0.00%
GKOSGlaukos Corporation $161.29 -6.32% -50.38 $9.51B 0.00%
HROWHarrow, Inc. $30.52 -0.33% -30.94 $1.14B 0.00%
KODKodiak Sciences Inc $94.26 +3.49% -22.54 $5.90B 0.00%

About Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. (OCUL) stock trades at $7.51 with a market capitalization of $1.64B. The stock is valued at a price-to-earnings (P/E) ratio of -5.56, price-to-book of 3.42, price-to-sales of 33.21. Over the past 52 weeks the stock has ranged between $6.23 and $16.44, and currently trades 54.3% below its 52-week high.

On profitability, Ocular Therapeutix, Inc. generates a return on equity (ROE) of -59.87%, return on capital employed of -50.46%, an operating margin of -8.65%, a net profit margin of -579.10%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides